Spero Therapeutics logo Spero Therapeutics (NASDAQ:SPRO) posted its quarterly earnings data on Thursday. The company reported ($36.02) earnings per share for the quarter, missing the Zacks' consensus estimate of ($2.43) by ($33.59), Bloomberg Earnings ...
more»